abrdn Investment Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
abrdn Investment Management's CELG Position: Q2 2017 in Review
abrdn Investment Management increased its Celgene Corp (CELG) stake by 12% in Q2 2017, buying an estimated $45.5M and bringing the position to 3,558,666 shares worth $462M. The position accounts for 1.56% of the portfolio, ranked #13.
abrdn Investment Management first reported a position in CELG in Q2 2013 and has held it in 17 quarters since. The position peaked at $471M in Q1 2015. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.
- abrdn Investment Management held 3,558,666 shares of Celgene Corp worth $462M as of Q2 2017.
- abrdn Investment Management bought 370,943 Celgene Corp shares in Q2 2017, an estimated $45.5M.
- Celgene Corp made up 1.56% of abrdn Investment Management's portfolio in Q2 2017, its #13 holding.
- abrdn Investment Management first reported a position in Celgene Corp in Q2 2013 and has held it in 17 quarters since.
- abrdn Investment Management's Celgene Corp position peaked at $471M in Q1 2015.
- 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.
Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.